melphalan and Urogenital-Neoplasms

melphalan has been researched along with Urogenital-Neoplasms* in 4 studies

Trials

1 trial(s) available for melphalan and Urogenital-Neoplasms

ArticleYear
Concurrent combination chemotherapy of human solid tumors: experience with a three-drug regimen and review of the literature.
    Cancer research, 1969, Volume: 29, Issue:2

    Topics: Adolescent; Adult; Aged; Bone Marrow; Bone Neoplasms; Carcinoma; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Drug Synergism; Female; Fluorouracil; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Melphalan; Middle Aged; Mitomycins; Parotid Neoplasms; Sarcoma; Urogenital Neoplasms; Vincristine

1969

Other Studies

3 other study(ies) available for melphalan and Urogenital-Neoplasms

ArticleYear
Chemotherapy of genitourinary malignancies.
    Seminars in drug treatment, 1973,Summer, Volume: 3, Issue:1

    Topics: Adenocarcinoma; Bleomycin; Carcinoma, Squamous Cell; Castration; Dactinomycin; Estrogens; Female; Humans; Kidney Neoplasms; Male; Melphalan; Nitrosourea Compounds; Phosphorus Isotopes; Plicamycin; Prostatic Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms; Vinblastine; Vincristine

1973
[Indication and achievements of after-care examinations of urologic tumors. Chemotherapeutic report].
    Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1973, Volume: 0, Issue:0

    Topics: Aftercare; Antineoplastic Agents; Bleomycin; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Mitomycins; Plicamycin; Postoperative Complications; Procarbazine; Urogenital Neoplasms; Vinblastine

1973
Chemotherapy in advanced malignant diseases in Iraq.
    Annals of the Royal College of Surgeons of England, 1971, Volume: 49, Issue:6

    This work discusses the experience of one surgical team in the Third Surgical Unit at the Republican Teaching Hospital, Baghdad, from 1967 to 1970. 112 patients with advanced malignant lesions in various parts of the body were dealt with. In 84, the intra-arterial route was adopted; in the remaining, systemic administration of cytotoxic agents either singly or in combination was employed. The results are reported in terms of subjective and objective response, and the various complications are discussed.

    Topics: Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Cancer, Regional Perfusion; Cyclophosphamide; Female; Head and Neck Neoplasms; Humans; Injections, Intra-Arterial; Iraq; Male; Melphalan; Methotrexate; Mouth Neoplasms; Podophyllin; Stomach Neoplasms; Urogenital Neoplasms

1971